213 related articles for article (PubMed ID: 3023310)
1. Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.
Yoshie O; Tada K; Ishida N
J Biochem; 1986 Sep; 100(3):531-41. PubMed ID: 3023310
[TBL] [Abstract][Full Text] [Related]
2. Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.
Kull FC; Jacobs S; Cuatrecasas P
Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5756-60. PubMed ID: 2994048
[TBL] [Abstract][Full Text] [Related]
3. Characterization and affinity crosslinking of receptors for tumor necrosis factor on human cells.
Tsujimoto M; Feinman R; Kohase M; Vilcek J
Arch Biochem Biophys; 1986 Sep; 249(2):563-8. PubMed ID: 3019243
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of membrane receptors for human natural and recombinant 125I-labeled tumor necrosis factor on HeLa cell clones and their role in tumor cell sensitivity.
Lehmann V; Dröge W
Eur J Biochem; 1986 Jul; 158(1):1-5. PubMed ID: 3015605
[TBL] [Abstract][Full Text] [Related]
5. Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines.
Scheurich P; Ucer U; Krönke M; Pfizenmaier K
Int J Cancer; 1986 Jul; 38(1):127-33. PubMed ID: 3087891
[TBL] [Abstract][Full Text] [Related]
6. Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition.
Baglioni C; McCandless S; Tavernier J; Fiers W
J Biol Chem; 1985 Nov; 260(25):13395-7. PubMed ID: 2997166
[TBL] [Abstract][Full Text] [Related]
7. Bioactive human recombinant tumor necrosis factor-alpha: an unstable dimer?
Petersen CM; Nykjaer A; Christiansen BS; Heickendorff L; Mogensen SC; Møller B
Eur J Immunol; 1989 Oct; 19(10):1887-94. PubMed ID: 2583226
[TBL] [Abstract][Full Text] [Related]
8. High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors.
Rubin BY; Anderson SL; Sullivan SA; Williamson BD; Carswell EA; Old LJ
J Exp Med; 1985 Sep; 162(3):1099-104. PubMed ID: 2993471
[TBL] [Abstract][Full Text] [Related]
9. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.
Brockhaus M; Schoenfeld HJ; Schlaeger EJ; Hunziker W; Lesslauer W; Loetscher H
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3127-31. PubMed ID: 2158104
[TBL] [Abstract][Full Text] [Related]
10. Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (tumor necrosis factor-beta) on a human histiocytic lymphoma cell line, U-937.
Stauber GB; Aggarwal BB
J Biol Chem; 1989 Feb; 264(6):3573-6. PubMed ID: 2536752
[TBL] [Abstract][Full Text] [Related]
11. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.
Loetscher H; Gentz R; Zulauf M; Lustig A; Tabuchi H; Schlaeger EJ; Brockhaus M; Gallati H; Manneberg M; Lesslauer W
J Biol Chem; 1991 Sep; 266(27):18324-9. PubMed ID: 1655744
[TBL] [Abstract][Full Text] [Related]
12. Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors.
Smith RA; Kirstein M; Fiers W; Baglioni C
J Biol Chem; 1986 Nov; 261(32):14871-4. PubMed ID: 3021754
[TBL] [Abstract][Full Text] [Related]
13. A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity.
Creasey AA; Yamamoto R; Vitt CR
Proc Natl Acad Sci U S A; 1987 May; 84(10):3293-7. PubMed ID: 3033642
[TBL] [Abstract][Full Text] [Related]
14. The active form of tumor necrosis factor is a trimer.
Smith RA; Baglioni C
J Biol Chem; 1987 May; 262(15):6951-4. PubMed ID: 3034874
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.
Tsujimoto M; Yip YK; Vilcek J
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7626-30. PubMed ID: 2999773
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.
Pennica D; Kohr WJ; Fendly BM; Shire SJ; Raab HE; Borchardt PE; Lewis M; Goeddel DV
Biochemistry; 1992 Feb; 31(4):1134-41. PubMed ID: 1310420
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor.
Pennica D; Lam VT; Weber RF; Kohr WJ; Basa LJ; Spellman MW; Ashkenazi A; Shire SJ; Goeddel DV
Biochemistry; 1993 Mar; 32(12):3131-8. PubMed ID: 8384489
[TBL] [Abstract][Full Text] [Related]
18. Selective formation of tumor necrosis factor-alpha (TNF) degradation products contributes to TNF mediated cytotoxicity.
Fruehauf JP; Sinha BK
Oncol Res; 1992; 4(3):91-101. PubMed ID: 1319775
[TBL] [Abstract][Full Text] [Related]
19. Characterization of specific high-affinity receptor for human lymphotoxin.
Hirano K; Yamamoto K; Kobayashi Y; Osawa T
J Biochem; 1989 Jan; 105(1):120-6. PubMed ID: 2544572
[TBL] [Abstract][Full Text] [Related]
20. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
